Skip NavigationSkip to Content

Synthesis and anti-breast cancer activity of novel indibulin related diarylpyrrole derivatives

  1. Author:
    Saeedian Moghadam, Ebrahim
    Hamel,Ernest
    Shahsavari, Zahra
    Amini, Mohsen
  2. Author Address

    Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design & Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, 1417614411, Iran., Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA., Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design & Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, 1417614411, Iran. moamini@tums.ac.ir.,
    1. Year: 2019
    2. Date: Jun
    3. Epub Date: 2019 03 20
  1. Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
    1. 27
    2. 1
    3. Pages: 179-189
  2. Type of Article: Article
  3. ISSN: 2008-2231
  1. Abstract:

    BackgroundDuring recent years, a number of anti-tubulin agents were introduced for treatment of diverse types of cancer. Despite their potential in the treatment of cancer, drug resistance and adverse toxicity, such as peripheral neuropathy, are some of the negative effects of anti-tubulin agents. Among anti-tubulin agents, indibulin was found to cause minimal peripheral neuropathy. Thus far, however, indibulin has not entered clinical usage, caused in part by its poor aqueous solubility and other developmental problems in preclinical evaluation.ObjectivesWith respect to need for finding potent and safe anticancer agents, in our current research work, we synthesized several indibulin-related diarylpyrrole derivatives and investigated their anti-cancer activity.MethodsCell cultur studies were perfomred using the MTT cell viability assay on the breast cancer cell lines MCF-7, T47-D, and MDA-MB231 and also NIH-3T3 cells as representative of a normal cell line. The activity of some of the synthesized compounds for tubulin interaction was studied using colchicine binding and tubulin polymerization assays. The annexin V-FITC/PI method and flow cytometric analysis were used for studying apoptosis induction and cell cycle distribution.Results and conclusionTwo of the synthesized compounds, 4f and 4g, showed high activity on the MDA-MB231 cell line (IC50=11.82 and 13.33M, (respectively) and low toxicity on the normal fibroblast cells (IC50>100M). All of the tested compounds were more potent on T47-D cancer cells and less toxic on NIH-3T3 normal cells in comparison to reference compound, indibulin. The tubulin polymerization inhibition assay and [H-3]colchicine binding assay showed that the main mechanism of cell death by the potent synthesized compounds was not related to an interaction with tubulin. In the annexin V/PI staining assay, the induction of apoptosis in the MCF-7 and MDA-MB231 cell lines was observed. Cell cycle analysis illustrated an increased percentage of sub-G-1 cells in the MDA-MB231 cell line as a further indication of cell death through induction of apoptosis.

    See More

External Sources

  1. DOI: 10.1007/s40199-019-00260-9
  2. PMID: 30891679
  3. PMCID: PMC6593016
  4. WOS: 000472907200018
  5. PII : 10.1007/s40199-019-00260-9

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel